ZG16 and colorectal carcinoma: A notable finding of this study is that CLCA1, UGT2A3, and ZG16—three genes highly expressed in normal colorectal tissues—are consistently downregulated in tumor tissues, suggesting that their loss may represent a coordinated event in CRC progression.